Jump Financial’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Jump Financial’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,820	Closed	-$326K	–	2392
2023 Q3	$326K	Sell	2,820 -1,298	-32%	-$139K	0.01%	1255
2023 Q2	$424K	Buy	+4,118	New	+$434K	0.02%	1116
2023 Q1	–	Sell	-1,897	Closed	-$216K	–	2205
2022 Q4	$216K	Buy	+1,897	New	+$158K	0.01%	1245
2022 Q3	–	Sell	-54,332	Closed	-$4.33M	–	2145
2022 Q2	$4.33M	Buy	54,332 +39,271	+261%	+$3.72M	0.19%	144
2022 Q1	$1.58M	Buy	+15,061	New	+$1.47M	0.07%	349
2021 Q4	–	Sell	-2,868	Closed	-$314K	–	1876
2021 Q3	$314K	Buy	2,868 +620	+28%	+$64.4K	0.02%	641
2021 Q2	$211K	Buy	+2,248	New	+$207K	0.02%	836
2020 Q4	–	Sell	-7,766	Closed	-$603K	–	1278
2020 Q3	$603K	Buy	+7,766	New	+$534K	0.12%	264

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jump Financial's HZNP Position: Q4 2023 in Review

Jump Financial sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,820 shares — an estimated $326K sold.

Jump Financial first reported a position in HZNP in Q3 2020 and held it in 8 quarters. The position peaked at $4.33M in Q2 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Jump Financial reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Jump Financial sold 2,820 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $326K.
Jump Financial first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 8 quarters.
Jump Financial's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.33M in Q2 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.